Trials / Unknown
UnknownNCT06035406
A Trial of SP2086 With Hepatic Insufficiency
Pharmacokinetics and Safety of SP2086 in Subjects With Mild and Moderate Liver Impairment and Normal Liver Function.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study used a single-dose, open design to compare the pharmacokinetics of subjects with mild and moderate liver impairment and subjects with normal liver function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Retagliptin Phosphate Tablet | Retagliptin Phosphate Tablet;100mg |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-09-13
- Last updated
- 2023-09-13
Source: ClinicalTrials.gov record NCT06035406. Inclusion in this directory is not an endorsement.